Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors

被引：0

作者：

Carol H. Wysham

Patrick Lefebvre

Dominic Pilon

Mike Ingham

Marie-Hélène Lafeuille

Bruno Emond

Rhiannon Kamstra

Wing Chow

Michael Pfeifer

Mei Sheng Duh

机构：

[1] Rockwood Clinic,

[2] Groupe d’analyse,undefined

[3] Ltée,undefined

[4] Janssen Scientific Affairs,undefined

[5] LLC,undefined

[6] Johnson & Johnson,undefined

[7] Analysis Group,undefined

[8] Inc.,undefined

来源：

BMC Endocrine Disorders | / 17卷

关键词：

Canagliflozin; Type 2 diabetes mellitus; Dipeptidyl peptidase-4 inhibitor; HbA1c; Blood pressure; Weight loss;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
Choi, Yeo Jin
Kim, Dae Jung
Shin, Sooyoung
CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7427 - 7438
[32] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
Mkele, Gail
SA PHARMACEUTICAL JOURNAL, 2013, 80 (02) : 17 - 19
[33] The Role of Dipeptidyl Peptidase-4 Inhibitors in Fat Metabolism in Patients with Type 2 Diabetes
Ametov, Alexander S.
DIABETES, 2017, 66 : A627 - A627
[34] Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus
Dave, Darshan J.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (04) : 230 - 235
[35] Potential Anti-Atherosclerotic Effects of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus
Sandeep Dhindsa
Ishwarlal Jialal
Current Diabetes Reports, 2014, 14
[36] Effect of Dipeptidyl Peptidase-4 Inhibitors on Adenosine Deaminase Activity in Type-2 Diabetes Mellitus
Jhajharia, Sumit
Pradhan, Tapaswini
Ekka, Anjana
Das, Ashok Kumar
BIOMEDICAL RESEARCH-INDIA, 2014, 25 (04): : 489 - 493
[37] SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Lizan, L.
Aceituno, S.
Franch, J.
Perez, A.
Granell, M.
Fuster, E.
VALUE IN HEALTH, 2014, 17 (07) : A348 - A348
[38] Linagliptin: The Newest Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes Mellitus
Aletti, Rachael
Cheng-Lai, Angela
CARDIOLOGY IN REVIEW, 2012, 20 (01) : 45 - 51
[39] Potential Anti-Atherosclerotic Effects of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus
Dhindsa, Sandeep
Jialal, Ishwarlal
CURRENT DIABETES REPORTS, 2014, 14 (02)
[40] Meta-analysis of dipeptidyl peptidase-4 inhibitors use and cardiovascular risk in patients with type 2 diabetes mellitus
Kaneko, Masayuki
Narukawa, Mamoru
DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 116 : 171 - 182

← 1 2 3 4 5 →